Trials / Conditions / PR-Positive Breast Cancer
PR-Positive Breast Cancer
6 registered clinical trials studyying PR-Positive Breast Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Supporting Health Including Endocrine Treatment for Long Duration NCT07482384 | Dana-Farber Cancer Institute | N/A |
| Withdrawn | Fulvestrant + Neratinib In Breast Cancer NCT04901299 | Massachusetts General Hospital | Phase 2 |
| Recruiting | PRE-I-SPY Phase I/Ib Oncology Platform Program NCT05868226 | QuantumLeap Healthcare Collaborative | Phase 1 |
| Recruiting | Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast NCT04886531 | Ruth O'Regan | Phase 2 |
| Terminated | Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered NCT04504331 | Jennifer Lee Caswell-Jin | Phase 1 |
| Terminated | A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) NCT04504916 | VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 2 |